Silex Systems Ltd (ASX: SLX) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Silex Systems Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$642.88 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
238.10 million
Earnings per share
-0.129
Dividend per share
N/A
Year To Date Return
-35.45%
Earnings Yield
N/A
Franking
-
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Silex Systems Ltd (ASX: SLX)
Latest News
Share Gainers
These were the 5 top-performing ASX All Ords shares of 2022
Share Gainers
5 ASX shares that have crushed the market this year
Technology Shares
Here's how ASX tech shares fared in September
Earnings Results
3 ASX All Ords shares that leapt higher on FY22 results today
Technology Shares
3 ASX tech shares leaping by more than 10% on Tuesday
Resources Shares
The ASX shares with 30% to 50% upside: fundie
52-Week Highs
3 ASX All Ordinaries shares hitting new 52-week highs on Wednesday
52-Week Highs
Rocks and lasers: 2 ASX All Ords shares securing new multi-year highs on Wednesday
Technology Shares
Here's a look at the 5 best ASX All Ords tech shares in FY22
Share Gainers
Guess which ASX All Ords share soared 21% to an 8-year high on Monday
Share Gainers
5 best ASX All Ordinaries shares in June
Technology Shares
Amid the carnage, this ASX tech share just hit an 8-year high
SLX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Silex Systems Ltd
Silex Systems Ltd is an Australian research and development company. The company focused on the development of the SILEX laser uranium enrichment technology as the next-generation technology for the uranium enrichment industry. The company's operating segment includes Silex Systems; Silex USA, and Translucent. It generates maximum revenue from the Silex Systems segment.
SLX Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 May 2025 | $3.12 | $-0.14 | -4.29% | 787,763 | $3.21 | $3.31 | $3.10 |
| 02 May 2025 | $3.26 | $0.11 | 3.49% | 899,111 | $3.28 | $3.29 | $3.14 |
| 01 May 2025 | $3.15 | $0.06 | 1.94% | 894,144 | $3.08 | $3.27 | $3.08 |
| 30 Apr 2025 | $3.09 | $0.09 | 3.00% | 1,539,069 | $2.97 | $3.09 | $2.91 |
| 29 Apr 2025 | $3.00 | $0.24 | 8.70% | 902,015 | $2.79 | $3.02 | $2.77 |
| 28 Apr 2025 | $2.76 | $-0.01 | -0.36% | 811,617 | $2.85 | $2.91 | $2.72 |
| 24 Apr 2025 | $2.77 | $0.14 | 5.32% | 1,520,383 | $2.67 | $2.80 | $2.65 |
| 23 Apr 2025 | $2.63 | $0.19 | 7.79% | 1,924,859 | $2.52 | $2.65 | $2.44 |
| 22 Apr 2025 | $2.44 | $-0.30 | -10.95% | 2,972,139 | $2.67 | $2.68 | $2.28 |
| 17 Apr 2025 | $2.74 | $0.09 | 3.40% | 1,517,377 | $2.66 | $2.75 | $2.62 |
| 16 Apr 2025 | $2.65 | $-0.17 | -6.03% | 928,702 | $2.74 | $2.79 | $2.64 |
| 15 Apr 2025 | $2.82 | $-0.04 | -1.40% | 871,977 | $2.94 | $2.94 | $2.74 |
| 14 Apr 2025 | $2.86 | $0.06 | 2.14% | 1,743,288 | $2.95 | $2.98 | $2.77 |
| 11 Apr 2025 | $2.80 | $-0.12 | -4.11% | 1,590,692 | $2.80 | $2.82 | $2.72 |
| 10 Apr 2025 | $2.92 | $0.17 | 6.18% | 1,941,083 | $3.01 | $3.12 | $2.92 |
| 09 Apr 2025 | $2.75 | $-0.31 | -10.13% | 1,509,545 | $2.97 | $2.97 | $2.75 |
| 08 Apr 2025 | $3.06 | $0.14 | 4.79% | 1,551,486 | $3.00 | $3.14 | $2.98 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 03 Mar 2025 | Michael Goldsworthy | Sell | 450,000 | $1,800,000 |
On-market trade.
|
| 03 Mar 2025 | Michael Goldsworthy | Buy | 450,000 | $367,500 |
Exercise of options.
|
| 03 Mar 2025 | Michael Goldsworthy | Exercise | 450,000 | $367,500 |
Exercise of options.
|
| 18 Oct 2024 | Michael Goldsworthy | Issued | 75,000 | $379,500 |
Issue of securities. 487,500 Performance Rights
|
| 05 Sep 2024 | Michael Goldsworthy | Expiry | 4,875 | $17,306 |
As advised by the company. Cessation, 482,625 Rights
|
| 05 Sep 2024 | Michael Goldsworthy | Issued | 70,125 | $248,943 |
Conversion of securities.
|
| 05 Sep 2024 | Michael Goldsworthy | Exercise | 70,125 | $248,943 |
Conversion of securities. 412,500 Performance Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Michael Philip Goldsworthy | Chief Executive OfficerManaging Director | Feb 1992 |
Mr Goldsworthy founder of the Company and co-inventor of the SILEX laser isotope separation technology. Dr Goldsworthy has been the guiding force behind the commercialization program for the SILEX technology. He is also Director of Global Laser Enrichment Holdings LLC.
|
| Mr Christopher David Wilks | Non-Executive Director | Sep 2007 |
Mr Wilks finance director and CFO of Sonic Healthcare Limited. He has held various directorships of public companies held over the years.
|
| Ms Susan (Susie) Corlett | Non-Executive Director | Nov 2024 |
Ms Corlett is a professional company director following an executive career in mining, investment banking and private equity. She joins the Board with experience in global mining finance, project development and operations, governance and risk management. Susie has experience gained from her time at Standard Bank Limited, Deutsche Bank and Macquarie Bank, and a track record of multi-jurisdictional cross-border transactions.
|
| Mr Craig Andrew Roy | Non-Executive ChairmanNon-Executive Director | Jan 2019 |
Mr Roy former Deputy CEO of the CSIRO. He has experience as a company director and is currently a Non-executive Director of Sydney Water and Chair of the Australian Research Data Commons.
|
| Ms Julie E Ducie | Company SecretaryChief Financial Officer | Oct 2010 |
-
|
| Julie E Ducie | Company SecretaryChief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 30,721,743 | 12.97% |
| Jardvan Pty Ltd | 29,801,030 | 12.58% |
| JP Morgan Nominees Australia Pty Limited | 16,976,422 | 7.17% |
| Citicorp Nominees Pty Limited | 7,895,945 | 3.33% |
| Majenta Holdings Pty Ltd | 5,703,923 | 2.41% |
| Hillboi Nominees Pty Ltd | 4,369,317 | 1.84% |
| Pure Gold Pty Ltd | 3,951,944 | 1.67% |
| UBS Nominees Pty Ltd | 3,614,225 | 1.53% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 3,132,177 | 1.32% |
| Spar Nominees Pty Ltd | 3,050,234 | 1.29% |
| Throvena Pty Ltd | 2,978,203 | 1.26% |
| Mr Christopher David Wilks | 2,405,070 | 1.02% |
| BNP Paribas Noms Pty Ltd | 2,400,928 | 1.01% |
| Hamlac Pty Ltd | 2,125,937 | 0.90% |
| National Nominees Limited | 1,988,102 | 0.84% |
| HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 1,884,235 | 0.80% |
| RD Super Pty Ltd | 1,805,082 | 0.76% |
| Sporran Lean Pty Ltd | 1,705,500 | 0.72% |
| BNP Paribas Nominees Pty Ltd <HUB24 Custodial Services Ltd> | 1,693,727 | 0.72% |
| Quintal Pty Ltd | 1,502,952 | 0.63% |